Tender detail
Open-house pharmaceutical rebate agreements for medicines containing ertugliflozin
Summary
The procurement concerns non-exclusive pharmaceutical rebate agreements for medicines containing the active ingredient ertugliflozin (ATC A10BK04). Agreements may be concluded at any time under the open-house model and will cover the period from 1 December 2026 to 30 November 2028. Medicines included on the list of paediatric medicines are excluded.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.